New investor Dell Technologies Capital leads round; all existing investors participate SAN DIEGO – Edico Genome announced today it has raised $22 million in a Series B financing to expand market adoption and product development of its DRAGEN™ platform, an end-to-end solution for analysis of next-generation sequencing data. New investor Dell Technologies Capital, the venture arm […]

MORGANTOWN, W.Va. and KALAMAZOO, Mich. — Protea Biosciences Group, Inc. (OTCQB: PRGB) (“Protea”) and Proteos, Inc. (“Proteos”) announced today that they have entered into a joint co-marketing agreement.  This mutual partnership allows Protea to combine Proteos’ protein production capabilities alongside Protea’s proprietary bioanalytical services, and allows Proteos to market and promote Protea’s proprietary bioanalytical services with their […]

Research insights from ultra-rapid whole genome sequencing are being used at California’s largest children’s hospital to improve care of critically-ill newborns MOUNTAIN VIEW, Calif.—-DNAnexus, the global leader in genome informatics and data management, announced that Rady Children’s Institute for Genomic Medicine (RCIGM) in San Diego has adopted the DNAnexus Platform to enable the world’s fastest […]

Bozeman, MT — Today, Golden Helix, Inc. announced a multi-year partnership with Sentieon, a company that develops bioinformatics secondary analysis tools to process genomic data. This partnership will integrate Sentieon’s secondary analysis tool with Golden Helix software to provide users with a comprehensive solution for genomic data analysis. Sentieon’s suite of secondary analysis tools made […]

Cambridge, UK – Congenica, a world leader in clinical genomics software for inherited diseases, today announced completion of its recently announced Series B funding round with additional investments from new strategically important investors BGI Genomics (BGI), a recognized global leader in genomics, Healthlink Capital (Healthlink), another well-established China-based life-science investor and Future Planet Capital, a global […]

HATFIELD, Pa. — Genisphere LLC, provider of the 3DNA® drug delivery platform, has signed a collaborative and sponsored research agreement with the University of Maryland, through Dr. Silvia Muro. The overall goal of the partnership is to study the pharmacokinetics and pharmacodynamics of various 3DNA designs and formulations after in vivo administration. Additional aims involve targeting diseases […]

Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of modeling and simulation software and consulting services for the pharmaceutical, biotechnology, and chemicals industries, today announced that it has signed a distributor agreement in India with Electrolab India Pvt. Ltd. John DiBella, vice president for marketing and sales of Simulations Plus, said: “The Indian pharmaceutical market […]

SAN DIEGO and CAMBRIDGE, ENGLAND –– Congenica and Edico Genome today announced the companies have partnered to offer their complementary platform technologies as an all-in-one, genome data analysis solution that accelerates clinical labs’ and hospitals’ progression from DNA sequencing to diagnosis for inherited diseases, which otherwise can take months or years, while also reducing costs. […]

A certified CDISC provider and leader in pharmacometrics, Certara has developed a new solution which will enable sponsors to achieve new compliance requirements effortlessly PRINCETON, NJ – Certara®, the leading provider of decision support technology and consulting services for optimizing drug development and improving health outcomes, today announced the launch of a new solution for preparing, […]